Javascript must be enabled to continue!
Investigation of The Prevalence of Secondary Bacterial Infection Associated with COVID-19 In Baghdad and Diyala Province
View through CrossRef
Background: Coronavirus disease 2019 (COVID-19) is an epidemic disease produced via the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) beta coronavirus, which affects the lower respiratory tract. Secondary bacterial infection (SBI) is a serious and public problem in patients hospitalized with COVID-19 and caused 50% of deaths. Type A and O blood groups are more susceptible to infection with SBIs.
Objective: To examine the relationship between SBI and ABO blood group with COVID-19 hospitalized patients in Baghdad and Diyala province.
Methods: Three hundred and forty-two patients with COVID-19 were collected from several sources (nasal swab, pharyngeal swab, sputum, blood, and urine) of patients of different ages for the period between September to November 2021. Real-time reverse-transcription polymerase chain reaction technique was used to diagnose COVID-19 in the patients as well as selective and differential media, biochemical tests BACT/ALERT system, and VITEK 2 compact system were used to diagnose the isolates of SBIs. The disk diffusion technique was used to assess the susceptibility test of all isolates. ABO group analysis was done for totally patients with COVID-19 under the study.
Results: Antimicrobial sensitivity test showed all SBIs were highly strong resistant to antibiotics. Fifty-seven isolates of bacteria were diagnosed including Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, and Escherichia coli. Group A and O showed a higher rate of acquired SBIs. Duration of infection with COVID-19 showed 61% for 10 days and 30% for one month while 9% in the patients infected with SBI for more than one month. The result appeared that SBIs infection at were very high rate in COVID-19 patients who had untreated antibiotics compared with the patient treated with antibiotics through the duration of infection.
Conclusion: The study revealed that many COVID-19 patients were more susceptible to infection with SBIs, especially in the early days of infection as well as there was a correlation between ABO blood groups and SBIs of COVID-19 patients.
Keywords: COVID-19; SBIs, AST, ABO blood group
Citation: Albadri AF, Alzubaidy ZM. Investigation of the prevalence of secondary bacterial infection associated with COVID-19 in Baghdad and Diyala province. Iraqi JMS. 2022; 20(2): 252-261. doi: 10.22578/IJMS.20.2.13
College of Medicine, Alnahrain University
Title: Investigation of The Prevalence of Secondary Bacterial Infection Associated with COVID-19 In Baghdad and Diyala Province
Description:
Background: Coronavirus disease 2019 (COVID-19) is an epidemic disease produced via the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) beta coronavirus, which affects the lower respiratory tract.
Secondary bacterial infection (SBI) is a serious and public problem in patients hospitalized with COVID-19 and caused 50% of deaths.
Type A and O blood groups are more susceptible to infection with SBIs.
Objective: To examine the relationship between SBI and ABO blood group with COVID-19 hospitalized patients in Baghdad and Diyala province.
Methods: Three hundred and forty-two patients with COVID-19 were collected from several sources (nasal swab, pharyngeal swab, sputum, blood, and urine) of patients of different ages for the period between September to November 2021.
Real-time reverse-transcription polymerase chain reaction technique was used to diagnose COVID-19 in the patients as well as selective and differential media, biochemical tests BACT/ALERT system, and VITEK 2 compact system were used to diagnose the isolates of SBIs.
The disk diffusion technique was used to assess the susceptibility test of all isolates.
ABO group analysis was done for totally patients with COVID-19 under the study.
Results: Antimicrobial sensitivity test showed all SBIs were highly strong resistant to antibiotics.
Fifty-seven isolates of bacteria were diagnosed including Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, and Escherichia coli.
Group A and O showed a higher rate of acquired SBIs.
Duration of infection with COVID-19 showed 61% for 10 days and 30% for one month while 9% in the patients infected with SBI for more than one month.
The result appeared that SBIs infection at were very high rate in COVID-19 patients who had untreated antibiotics compared with the patient treated with antibiotics through the duration of infection.
Conclusion: The study revealed that many COVID-19 patients were more susceptible to infection with SBIs, especially in the early days of infection as well as there was a correlation between ABO blood groups and SBIs of COVID-19 patients.
Keywords: COVID-19; SBIs, AST, ABO blood group
Citation: Albadri AF, Alzubaidy ZM.
Investigation of the prevalence of secondary bacterial infection associated with COVID-19 in Baghdad and Diyala province.
Iraqi JMS.
2022; 20(2): 252-261.
doi: 10.
22578/IJMS.
20.
2.
13.
Related Results
Burden of the Beast
Burden of the Beast
Introduction
Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
Isolation And Characterization Of Biosurfactant Producing Bacteria From Different Environmental Soil Samples
Isolation And Characterization Of Biosurfactant Producing Bacteria From Different Environmental Soil Samples
Biosurfactants are natural substances produced by several bacterial and fungal organisms that are amphiphilic and are extracellular (a part of the cell membrane). Biosurfactants ca...
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus , is causing a serious worldwide COVID-19 pandemic. The emergence of strains with rapid spread and...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Long COVID Treatment No Silver Bullets, Only a Few Bronze BBs
Long COVID Treatment No Silver Bullets, Only a Few Bronze BBs
Long COVID is the consequence of having had COVID. Long COVID has many other names including Long-haul COVID, Post-COVID conditions (PCC), Post-COVID-19 syndrome, Post-acute seque...
Long COVID Treatment No Silver Bullets, Only a Few Bronze BBs
Long COVID Treatment No Silver Bullets, Only a Few Bronze BBs
Long COVID is the consequence of having had COVID. Long COVID has many other names including Long-haul COVID, Post-COVID conditions (PCC), Post-COVID-19 syndrome, Post-acute seque...
COVID-19 Testing in Young Individuals and Pandemics Monitoring: Low Susceptibility to the Infection and Lack of Positive Results
COVID-19 Testing in Young Individuals and Pandemics Monitoring: Low Susceptibility to the Infection and Lack of Positive Results
Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV- 2), a novel betacoronavirus, is the etiological agent of coronavirus disease 2019 (COVID-19), a global health threat. The ...

